Execution of License Agreement on Flutiform, an Anti-asthmatic Treatment, in Japan
April 22, 2008
Execution of License Agreement on Flutiform™ , an Anti-asthmatic Treatment, in Japan Kyorin Pharmaceutical Co., Ltd. (Tokyo, President: Ikuo Ogihara), a subsidiary of Kyorin Co., Ltd., announces that it has entered into a License Agreement with SkyePharma PLC (United Kingdom, CEO: Mr. Frank Condella) as of April 22, 2008 on Flutiform™ , an anti-asthmatic treatment currently under development for Europe and the USA.
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.